Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 41.39 USD 4.94% Market Closed
Market Cap: 1.2B USD
Section:
 

Relative Value

The Relative Value of one CSTL stock under the Base Case scenario is 26.35 USD. Compared to the current market price of 41.39 USD, Castle Biosciences Inc is Overvalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSTL Relative Value
Base Case
26.35 USD
Overvaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
50
vs Industry
50
Median 3Y
2.5
Median 5Y
3.7
Industry
2.3
Forward
3.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
17
Median 3Y
-10.9
Median 5Y
-20.8
Industry
22.4
Forward
-36.1
More Details
19.5
P/OCF
P/OCF
Price to OCF
19.5
vs History
19
vs Industry
38
Median 3Y
8.5
Median 5Y
-11.1
Industry
14.4
More Details
47.8
P/FCFE
P/FCFE
Price to FCFE
47.8
vs History
12
vs Industry
29
Median 3Y
13.4
Median 5Y
-10.3
Industry
21.7
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
26
vs Industry
55
Median 3Y
1.5
Median 5Y
1.7
Industry
2.2
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
39
vs Industry
68
Median 3Y
1.6
Median 5Y
2.5
Industry
2.5
Forward
2.8
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
41
vs Industry
79
Median 3Y
1.9
Median 5Y
3.1
Industry
5.1
More Details
118.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
118.8
vs History
0
vs Industry
28
Median 3Y
-3.1
Median 5Y
-5.5
Industry
12
Forward
27.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
12
Median 3Y
-6
Median 5Y
-13.4
Industry
16.9
Forward
-17.6
More Details
15.1
EV/OCF
EV/OCF
Enterprise Value to OCF
15.1
vs History
17
vs Industry
49
Median 3Y
4.4
Median 5Y
-5.5
Industry
14.5
More Details
36.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.6
vs History
12
vs Industry
36
Median 3Y
-2.8
Median 5Y
-5.8
Industry
18.6
More Details
3.5
EV/IC
EV/IC
Enterprise Value to IC
3.5
vs History
28
vs Industry
50
Median 3Y
1.8
Median 5Y
2
Industry
1.8
More Details

Multiples Across Competitors

CSTL Competitors Multiples
Castle Biosciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Castle Biosciences Inc
NASDAQ:CSTL
1.2B USD 3.5 -98.6 118.8 -26.6
US
CVS Health Corp
NYSE:CVS
99.5B USD 0.3 212.2 14 14
US
Cigna Corp
NYSE:CI
73.5B USD 0.3 12 7.7 9.8
US
Cigna Group
XMUN:CGN
62B EUR 0.3 11.9 7.7 9.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR 1.2 23.9 10.4 15.9
DE
Fresenius Medical Care AG
XMUN:FME
23.7B EUR 1.2 33 10.4 22.1
US
Laboratory Corporation of America Holdings
NYSE:LH
21.2B USD 1.5 24.8 13.5 18.8
US
Quest Diagnostics Inc
NYSE:DGX
19.6B USD 1.8 20.3 11.3 15.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 16.5 6.4 13.7
US
Guardant Health Inc
NASDAQ:GH
12.7B USD 14 -31.8 -33.5 -30.4
US
DaVita Inc
NYSE:DVA
8.3B USD 0.6 10.7 6.7 9.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Castle Biosciences Inc
NASDAQ:CSTL
Average EV/EBIT: 14.3
Negative Multiple: -26.6 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
18%
0.8
US
Cigna Corp
NYSE:CI
9.8
4%
2.4
US
C
Cigna Group
XMUN:CGN
9.7
4%
2.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.9
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
22.1
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
18.8
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.2
11%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.7
25%
0.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -30.4 N/A N/A
US
DaVita Inc
NYSE:DVA
9.1
4%
2.3

See Also

Summary
CSTL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSTL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSTL stock valuation using valuation multiples.
Wall Street Estimates
CSTL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSTL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.